Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Daniel Geh, Quentin M Anstee & Helen L Reeves. (2021) NAFLD-Associated HCC: Progress and Opportunities. Journal of Hepatocellular Carcinoma 8, pages 223-239.
Read now
Read now
Articles from other publishers (10)
Saleh A. Alqahtani, Wah-Kheong Chan & Ming-Lung Yu. (2023) Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular Carcinoma. Clinics in Liver Disease 27:2, pages 211-223.
Crossref
Crossref
Siyu Liu, Liyang Sun, Lanqing Yao, Hong Zhu, Yongkang Diao, Mingda Wang, Hao Xing, Wan Yee Lau, Mingcheng Guan, Timothy M. Pawlik, Feng Shen, Min Xu, Xiangmin Tong & Tian Yang. (2022) Diagnostic Performance of AFP, AFP-L3, or PIVKA-II for Hepatitis C Virus-Associated Hepatocellular Carcinoma: A Multicenter Analysis. Journal of Clinical Medicine 11:17, pages 5075.
Crossref
Crossref
Daniel Geh, Robyn Watson, Gourab Sen, Jeremy J French, John Hammond, Paul Turner, Tim Hoare, Kirsty Anderson, Michael McNeil, Stuart McPherson, Steven Masson, Jessica Dyson, Mhairi Donnelly, Louise MacDougal, Preya Patel, Mark Hudson, Quentin M Anstee, Steven White, Stuart Robinson, Sanjay Pandanaboyana, Lucy Walker, Misti McCain, Yvonne Bury, Shreya Raman, Alastair Burt, Daniel Parkinson, Beate Haugk, Antony Darne, Nick Wadd, Syed Asghar, Lavanya Mariappan, Jane Margetts, Benjamin Stenberg, John Scott, Peter Littler, Derek M Manas & Helen L Reeves. (2022) COVID-19 and liver cancer: lost patients and larger tumours. BMJ Open Gastroenterology 9:1, pages e000794.
Crossref
Crossref
Magdalena Stepien, Pekka Keski‐Rahkonen, Agneta Kiss, Nivonirina Robinot, Talita Duarte‐Salles, Neil Murphy, Gabriel Perlemuter, Vivian Viallon, Anne Tjønneland, Agnetha Linn Rostgaard‐Hansen, Christina C. Dahm, Kim Overvad, Marie‐Christine Boutron‐Ruault, Francesca Romana Mancini, Yahya Mahamat‐Saleh, Krasimira Aleksandrova, Rudolf Kaaks, Tilman Kühn, Antonia Trichopoulou, Anna Karakatsani, Salvatore Panico, Rosario Tumino, Domenico Palli, Giovanna Tagliabue, Alessio Naccarati, Roel C.H. Vermeulen, Hendrik Bastiaan Bueno‐de‐Mesquita, Elisabete Weiderpass, Guri Skeie, Jose Ramón Quirós, Eva Ardanaz, Olatz Mokoroa, Núria Sala, Maria‐Jose Sánchez, José María Huerta, Anna Winkvist, Sophia Harlid, Bodil Ohlsson, Klas Sjöberg, Julie A. Schmidt, Nick Wareham, Kay‐Tee Khaw, Pietro Ferrari, Joseph A. Rothwell, Marc Gunter, Elio Riboli, Augustin Scalbert & Mazda Jenab. (2020) Metabolic perturbations prior to hepatocellular carcinoma diagnosis: Findings from a prospective observational cohort study. International Journal of Cancer 148:3, pages 609-625.
Crossref
Crossref
Sofi Dhanaraj, Tahir Shah, Joanne O'Rourke & Shishir Shetty. (2020) Hepatocellular carcinoma: update on treatment guidelines. Gastrointestinal Nursing 18:Sup10, pages S18-S26.
Crossref
Crossref
Xueqin Liu & Jian Xu. (2020) Calling a stage-based treatment model for chronic liver diseases in China mainland. Annals of Hepatology 19:6, pages 585-589.
Crossref
Crossref
Ariel Jaffe, Michael L. Schilsky, Ranjit Deshpande & Ramesh Batra. (2020) Liver Transplantation in the Time of COVID19: Barriers and Ethical Considerations for Management and Next Steps. Hepatology Communications 4:9, pages 1242-1256.
Crossref
Crossref
Amit G. Singal, Pietro Lampertico & Pierre Nahon. (2020) Epidemiology and surveillance for hepatocellular carcinoma: New trends. Journal of Hepatology 72:2, pages 250-261.
Crossref
Crossref
Jan Petrasek, Amit G. Singal & Nicole E. Rich. (2019) Harms of Hepatocellular Carcinoma Surveillance. Current Hepatology Reports 18:4, pages 383-389.
Crossref
Crossref
Renumathy Dhanasekaran & Dean W. Felsher. (2019) A Tale of Two Complications of Obesity: NASH and Hepatocellular Carcinoma. Hepatology 70:3, pages 1056-1058.
Crossref
Crossref